122 related articles for article (PubMed ID: 38251680)
1. The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis).
Yagasaki R; Morita A; Mori A; Sakamoto K; Nakahara T
Curr Eye Res; 2024 May; 49(5):505-512. PubMed ID: 38251680
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy.
Iizuka N; Morita A; Kawano C; Mori A; Sakamoto K; Kuroyama M; Ishii K; Nakahara T
J Pharmacol Sci; 2018 Nov; 138(3):203-208. PubMed ID: 30409713
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy.
Yagasaki R; Nakahara T; Ushikubo H; Mori A; Sakamoto K; Ishii K
Biol Pharm Bull; 2014; 37(11):1838-42. PubMed ID: 25366488
[TBL] [Abstract][Full Text] [Related]
4. Role of mammalian target of rapamycin in the formation and progression of retinopathy of prematurity-like vascular abnormalities in neonatal rats.
Nakano A; Morita A; Arima S; Nagamitsu T; Nakahara T
Microvasc Res; 2024 Mar; 152():104626. PubMed ID: 37963514
[TBL] [Abstract][Full Text] [Related]
5. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
Joe SG; Yoon YH; Choi JA; Koh JY
PLoS One; 2015; 10(3):e0119708. PubMed ID: 25785990
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of insulin-like growth factor binding protein-related protein 1 on retinal angiogenesis via ERK signaling pathway].
Zhang P; Wang H; Cao H; Xu X; Sun T
Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):207-211. PubMed ID: 28316197
[No Abstract] [Full Text] [Related]
10. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
Di Y; Zhang Y; Yang H; Wang A; Chen X
Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
[TBL] [Abstract][Full Text] [Related]
12. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
[TBL] [Abstract][Full Text] [Related]
13. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
14. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
[TBL] [Abstract][Full Text] [Related]
15. Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathy.
Shan S; Liu F; Ford E; Caldwell RB; Narayanan SP; Somanath PR
Biomed Pharmacother; 2023 Jun; 162():114714. PubMed ID: 37080089
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
Kolibabka M; Dietrich N; Klein T; Hammes HP
Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
[TBL] [Abstract][Full Text] [Related]
17. A Novel Hypoxia-inducible Factor 1α Inhibitor KC7F2 Attenuates Oxygen-induced Retinal Neovascularization.
Tang X; Cui K; Lu X; Wu P; Yu S; Yang B; Xu Y; Liang X
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):13. PubMed ID: 35695808
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
19. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Kim BH; Lee J; Choi JS; Park DY; Song HY; Park TK; Cho CH; Ye SK; Joo CK; Koh GY; Kim TY
Br J Pharmacol; 2015 Aug; 172(15):3875-89. PubMed ID: 25917462
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Liu N; Chen L; Cai N
Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
